Chordoma is a rare tumor that occurs along the axial spine in pediatrics and adults, with an
incidence of approximately 350 cases per year in the United States. While typically …

Cancer is one of the leading causes of death in humans because of the lack of early
diagnosis, distant metastases, and the resistance to adjuvant therapies, including …

Chordomas are rare tumors of notochordal origin, most commonly arising in the sacrum or
skull base. Chordomas are considered insensitive to conventional chemotherapy, and their …

Background Chordomas are rare malignant bone cancers of the skull-base and spine.
Patient survival is variable and not reliably predicted using clinical factors or molecular …

Objective: chordomas are rare bone tumors with few therapeutic options. Skull base and
sacrum are the two most common origin sites. Immunotherapies are emerging as the most …

Simple Summary Bone sarcomas are rare cancers coming from the mesenchyme cells of the
body skeletal system. Osteosarcoma, chondrosarcoma, Ewing sarcoma, and chordoma are …

Paclitaxel has been extensively used in clinics for cancer treatment. However, its limited
solubility in aqueous solution and high occurrence of side effects have also been widely …

Chordomas are uncommon, bone, axial, or (rarely) extra-axial tumors that are malignant and
frequently recur but less commonly metastasize. They usually affect adults, with a very small …

Simple Summary Surgery is the primary treatment for chordoma. However, residual or
recurrent chordoma presents a significant problem for clinicians. The aim of this work is to …

Background: Skull base chordoma is a rare tumor with low-grade malignancy and a high
recurrence rate, the factors affecting the prognosis of patients need to be further studied. For …